Orange Book product · Brand (NDA)
DOLOPHINE HYDROCHLORIDE
METHADONE HYDROCHLORIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
METHADONE HYDROCHLORIDE
Strength
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 006134
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —METHADOSEBrand (NDA)
NDA 017116 · SPECGX LLC
- —METHADONE HYDROCHLORIDEBrand (NDA)
NDA 021624 · MYLAN INSTITUTIONAL
- —METHADONE HYDROCHLORIDEBrand (NDA)
NDA 006383 · MALLINCKRODT INC
- —WESTADONEBrand (NDA)
NDA 017108 · SANDOZ
- —METHADONE HYDROCHLORIDEBrand (NDA)
NDA 017058 · HIKMA
- 2025METHADONE HYDROCHLORIDEGeneric (ANDA)
ANDA 218609 · HIKMA
- 2024METHADONE HYDROCHLORIDEGeneric (ANDA)
ANDA 218252 · BRECKENRIDGE
- 2021METHADONE HYDROCHLORIDEGeneric (ANDA)
ANDA 212094 · LANNETT CO INC
- 2020METHADONE HYDROCHLORIDEGeneric (ANDA)
ANDA 212093 · LANNETT CO INC
- 2020METHADONE HYDROCHLORIDEGeneric (ANDA)
ANDA 090635 · THEPHARMANETWORK LLC
- 2020METHADONE HYDROCHLORIDEGeneric (ANDA)
ANDA 204166 · VISTAPHARM LLC
- 2019METHADONE HYDROCHLORIDEGeneric (ANDA)
ANDA 207537 · SPECGX LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
